Literature DB >> 9452459

Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex.

J P Medema1, C Scaffidi, P H Krammer, M E Peter.   

Abstract

The Bcl-2 family member Bcl-xL has often been correlated with apoptosis resistance. We have shown recently that in peripheral human T cells resistance to CD95-mediated apoptosis is characterized by a lack of caspase-8 recruitment to the CD95 death-inducing signaling complex (DISC) and by increased expression of Bcl-xL (Peter, M. E., Kischkel, F. C., Scheuerpflug, C. G., Medema, J. P., Debatin, K.-M., and Krammer, P. H. (1997) Eur. J. Immunol. 27, 1207-1212). This raises the possibility that Bcl-xL directly prevents caspase-8 activation by the DISC. To test this hypothesis a cell line in which CD95 signaling was inhibited by overexpression of Bcl-xL was used. In these MCF7-Fas-bcl-xL cells Bcl-xL had no effect on the recruitment of caspase-8 to the DISC. It did not affect the activity of the DISC nor the generation of the caspase-8 active subunits p18 and p10. In contrast, cleavage of a typical substrate for caspase-3-like proteases, poly(ADP-ribose) polymerase, was inhibited in comparison with the control-transfected CD95-sensitive MCF7-Fas cells. To test whether Bcl-xL would inhibit active caspase-8 subunits in the cytoplasm, a number of immunoprecipitation experiments were performed. Using monoclonal antibodies directed against different domains of caspase-8, anti-Bcl-xL antibodies, or fusion proteins of glutathione S-transferase with different domains of caspase-8, no evidence for a direct or indirect physical interaction between caspase-8 and Bcl-xL was found. Moreover, overexpression of Bcl-xL did not inhibit the activity of the caspase-8 active subunits p18/p10. Therefore, in this cell line that has become resistant to CD95-induced apoptosis due to overexpression of Bcl-xL, Bcl-xL acts independently and downstream of caspase-8.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452459     DOI: 10.1074/jbc.273.6.3388

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

Authors:  Tae Woo Kim; Chien-Fu Hung; Morris Ling; Jeremy Juang; Liangmei He; J Marie Hardwick; Sharad Kumar; T-C Wu
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

2.  BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins.

Authors:  H Zhang; Q Xu; S Krajewski; M Krajewska; Z Xie; S Fuess; S Kitada; K Pawlowski; A Godzik; J C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling.

Authors:  L S Walker; J D McLeod; G Boulougouris; Y I Patel; C N Ellwood; N D Hall; D M Sansom
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

Review 4.  The Fas signaling connection between autoimmunity and embryonic lethality.

Authors:  H C Hsu; Y Matsuki; H G Zhang; T Zhou; J D Mountz
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

5.  Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation.

Authors:  Dean A Le; Yongqin Wu; Zhihong Huang; Kohji Matsushita; Nikolaus Plesnila; Jean C Augustinack; Bradley T Hyman; Junying Yuan; Keisuke Kuida; Richard A Flavell; Michael A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

6.  Molecular ordering of the initial signaling events of CD95.

Authors:  Alicia Algeciras-Schimnich; Le Shen; Bryan C Barnhart; Andrea E Murmann; Janis K Burkhardt; Marcus E Peter
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  The transcription factor Wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor α-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL.

Authors:  Hima Bansal; Theresea Seifert; Carlos Bachier; Manjeet Rao; Gail Tomlinson; Swaminathan Padmanabhan Iyer; Sanjay Bansal
Journal:  J Biol Chem       Date:  2012-08-16       Impact factor: 5.157

8.  Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia.

Authors:  Jun Yang; P K Epling-Burnette; Jeffrey S Painter; Jianxiang Zou; Fanqi Bai; Sheng Wei; Thomas P Loughran
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

9.  Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.

Authors:  Pachiyappan Kamarajan; Nian-Kang Sun; Chuck C-K Chao
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

10.  DEDD, a novel death effector domain-containing protein, targeted to the nucleolus.

Authors:  A H Stegh; O Schickling; A Ehret; C Scaffidi; C Peterhänsel; T G Hofmann; I Grummt; P H Krammer; M E Peter
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.